Abstract
Background Huperzine A is an important drug for treating Alzheimer's disease and mainly extracted from the Huperzia serrata . Nevertheless, the content of Huperzine A in Huperzia serrata is very low of 0.007% with growing circle of 8 to 10 years, and the chemical synthesis of Huperzine A still has some insurmountable limitations in the industrialized production. So, the available resources of Huperzine A for clinical treatment of Alzheimer's disease are scarce. The purpose of this work was to construct a biosynthesis platform based on the endophytic fungi from Huperzia serrata . Methods Based on the morphological characteristics and nuclear ribosomal DNA ITS sequences of endophytic fungi to complete the strain identification. Combined alkaloid precipitation with acid dye colorimetry, thin layer chromatography, high-performance liquid chromatography, liquid chromatography-tandem mass spectrometry analysis and inhibition activity of acetylcholinesterase determination model to determine the physicochemical properties of the biosynthetic products. Compare the biosynthetic HupA with the listed APIs of HupA by the test of AChE inhibition ability and cytotoxicity in vitro. Results In this work, five endophytic fungi Mucor racemosus NSH-D, Mucor fragilis NSY-1, Fusarium verticillioides NSH-5, Fusarium oxysporum NSG-1 and Trichoderma harzianum NSW-V were firstly found and isolated from the Chinese folk medicine Qian Ceng Ta ( Huperzia serrata (Thunb.) Trevis. (Lycopodiaceae)), which were identified according to their morphological characteristics and nuclear ribosomal DNA ITS sequences. These fungi could effectively biosynthesize huperzine A in liquid culture of 100-400 mg/L which were 1 000 times higher than that of other reported conventional endophytic fungi. Moreover, these fungi with higher hereditary stability could possess the initial express ability of HupA after 40 generations, and the expressed HupA from these biosynthesis systems has the prior physicochemical properties, better inhibition activity of acetylcholinesterase and lower cytotoxicity compared to the listed APIs of HupA. Conclusions These results indicate that the endophytic fungi in this work provide a promising alternative platform for producing HupA at industrial scale by biosynthesis for the treatment of Alzheimer's disease.